Literature DB >> 1328463

Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.

P Vandenabeele1, W Declercq, D Vercammen, M Van de Craen, J Grooten, H Loetscher, M Brockhaus, W Lesslauer, W Fiers.   

Abstract

We investigated the biological role of the human tumor necrosis factor p75 (hTNF-R75), making use of the species specificity of TNF responses in murine (m) T cell lines. Several TNF-mediated activities on mouse T cells, such as cytokine induction or proliferation, showed a 100-500-fold difference in specific biological activity between mTNF and hTNF. After transfection of hTNF-R75 cDNA in a rat/mouse T cell hybridoma (PC60), however, the 100-fold lower specific biological activity of hTNF was converted to the same specific biological activity as mTNF. The TNF-mediated induction of granulocyte/macrophage colony-stimulating factor was strongly synergized by the addition of interleukin 1. In the presence of the latter cytokine, ligand-competing monoclonal antibodies against hTNF-R75 (utr-1, utr-2, utr-3) were agonistic on transfected PC60 cells. This agonistic activity was further enhanced by crosslinking with sheep anti-murine immunoglobulin antibodies. These data provide direct evidence for a functional role of TNF-R75, without ligand-dependent TNF-R55 involvement, in the induction of cytokine secretion in T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328463      PMCID: PMC2119388          DOI: 10.1084/jem.176.4.1015

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  Lymphokines and monokines in anti-cancer therapy.

Authors:  W Fiers; P Brouckaert; R Devos; L Fransen; G Leroux-Roels; E Remaut; P Suffys; J Tavernier; J Van der Heyden; F Van Roy
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

2.  Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor.

Authors:  B Everaerdt; P Brouckaert; A Shaw; W Fiers
Journal:  Biochem Biophys Res Commun       Date:  1989-08-30       Impact factor: 3.575

3.  Simple, sensitive and specific bioassay of interleukin-1.

Authors:  S J Hopkins; M Humphreys
Journal:  J Immunol Methods       Date:  1989-06-21       Impact factor: 2.303

4.  A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

Authors:  C A Smith; T Davis; D Anderson; L Solam; M P Beckmann; R Jerzy; S K Dower; D Cosman; R G Goodwin
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

5.  Development of a simple, sensitive and specific bioassay for interleukin-1 based on the proliferation of RPMI 1788 cells. Comparison with other bioassays for IL-1.

Authors:  P Vandenabeele; W Declercq; C Libert; W Fiers
Journal:  J Immunol Methods       Date:  1990-12-31       Impact factor: 2.303

Review 6.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

7.  Species-specific TNF induction of thymocyte proliferation.

Authors:  M J Ehrke; R L Ho; K Hori
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.

Authors:  M R Shalaby; A Sundan; H Loetscher; M Brockhaus; W Lesslauer; T Espevik
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.

Authors:  G E Ranges; A Zlotnik; T Espevik; C A Dinarello; A Cerami; M A Palladino
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  24 in total

1.  Production of polyclonal antibodies to feline tumor necrosis factor.

Authors:  C M Otto; F Niagro; R A McGraw; C A Rawlings
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.

Authors:  Elke Kunisch; Muktheshwar Gandesiri; Reneé Fuhrmann; Andreas Roth; Rando Winter; Raimund W Kinne
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

3.  Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role.

Authors:  A Corti; L Fattorini; O F Thoresen; M L Ricci; A Gallizia; M Pelagi; Y Li; G Orefici
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.

Authors:  F Samad; K T Uysal; S M Wiesbrock; M Pandey; G S Hotamisligil; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

5.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.

Authors:  G Herbein; L J Montaner; S Gordon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Expression and localization of messenger RNA for tumor necrosis factor receptor (TNF-R) I and TNF-RII in pregnant mouse uterus and placenta.

Authors:  K F Roby; N Laham; H Kröning; P F Terranova; J S Hunt
Journal:  Endocrine       Date:  1995-08       Impact factor: 3.633

7.  55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  G Herbein; S Gordon
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.

Authors:  O J Jupp; S M McFarlane; H M Anderson; A F Littlejohn; A A Mohamed; R H MacKay; P Vandenabeele; D J MacEwan
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

9.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Authors:  C Ferran; F Dautry; S Mérite; K Sheehan; R Schreiber; G Grau; J F Bach; L Chatenoud
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

10.  Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.

Authors:  F R Lake; P W Noble; P M Henson; D W Riches
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.